Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Assertio Holdings, Inc. Common Stock (ASRT)

Pharmaceutical Preparations

https://www.assertiotx.com

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

100 S. SAUNDERS ROAD, SUITE 300
LAKE FOREST, IL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/05/1997

Market Cap

108,291,708

Shares Outstanding

94,670,000

Weighted SO

94,668,523

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

AGRX --.--%

AMRX --.--%

ACRX --.--%

LFCR --.--%

IRWD --.--%

NBIX --.--%

DCPH --.--%

ESPR --.--%

ANIP --.--%

Beta

0.9100

Last Div

0.0000

Range

0.73-3.47

Chg

0.0559

Avg Vol

1151577

Mkt Cap

108291708

Exch

NASDAQ

Country

US

Phone

224 419 7106

DCF Diff

-2.4513

DCF

3.7013

Div Yield

0.0000

P/S

0.8192

EV Multiple

8.3766

P/FV

0.8186

Div Yield %

0.0000

P/E

-0.3135

PEG

0.0010

Payout

0.0000

Current Ratio

1.9293

Quick Ratio

1.5054

Cash Ratio

0.4853

DSO

110.2102

DIO

263.1965

Op Cycle

373.4067

DPO

102.8474

CCC

270.5594

Gross Margin

0.5900

Op Margin

-1.8136

Pretax Margin

-2.0327

Net Margin

-2.6108

Eff Tax Rate

-0.2844

ROA

-1.2350

ROE

-2.3103

ROCE

-1.2802

NI/EBT

1.2844

EBT/EBIT

1.1208

EBIT/Rev

-1.8136

Debt Ratio

0.1410

D/E

0.2981

LT Debt/Cap

0.2266

Total Debt/Cap

0.2296

Int Coverage

-171.3631

CF/Debt

0.5884

Equity Multi

2.1145

Rec Turnover

3.3119

Pay Turnover

3.5489

Inv Turnover

1.3868

FA Turnover

70.9914

Asset Turnover

0.4730

OCF/Share

0.2434

FCF/Share

0.2453

Cash/Share

0.9280

OCF/Sales

0.1754

FCF/OCF

1.0078

CF Coverage

0.5884

ST Coverage

34.8586

CapEx Coverage

128.7833

Div&CapEx Cov

128.7833

P/BV

0.8186

P/B

0.8186

P/S

0.8192

P/E

-0.3135

P/FCF

4.6356

P/OCF

4.6669

P/CF

4.6669

PEG

0.0010

P/S

0.8192

EV Multiple

8.3766

P/FV

0.8186

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 17, 13:15 Assertio to Participate in Benchmark Healthcare Conference on May 21-22 GlobeNewswire Inc. May 17, 13:15 Assertio to Participate in Benchmark Healthcare Conference on May 21-22 GlobeNewswire Inc. May 17, 13:15 Assertio to Participate in Benchmark Healthcare Conference on May 21-22 GlobeNewswire Inc. May 17, 13:15 Assertio to Participate in Benchmark Healthcare Conference on May 21-22 GlobeNewswire Inc. May 17, 13:15 Assertio to Participate in Benchmark Healthcare Conference on May 21-22 Seeking Alpha Jan 08, 00:03 Assertio Holdings: Here's A Contrarian Opportunity In The Health Care Sector GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Jan 05, 18:56 Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 02, 12:06 Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023

Revenue Product Segmentation